What is the WHO recommended monitoring for patients with hepatitis B (HBV) (Hep B) during treatment or following treatment discontinuation?

Updated: Jun 08, 2021
  • Author: Nikolaos T Pyrsopoulos, MD, PhD, MBA, FACP, AGAF; Chief Editor: BS Anand, MD  more...
  • Print

Those receiving treatment or following treatment discontinuation. On-treatment monitoring is recommended at least every 3 months for the first year in/for the following:

  • Individuals with more advanced disease (compensated/decompensated cirrhosis)
  • Individuals coinfected with HBV/HIV
  • During the first year of treatment (to assess treatment response and adherence)
  • When treatment adherence is a concern
  • Individuals after treatment discontinuation

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!